logo
welcome
ScienceDaily

ScienceDaily

Scientists advance nanobody technology to combat deadly Ebola virus

ScienceDaily
Summary
Nutrition label

79% Informative

Researchers at the University of Minnesota and the Midwest Antiviral Drug Discovery (AViDD) Center have developed the first nanobody-based inhibitors targeting the Ebola virus.

Nanobodies are tiny antibodies derived from animals like alpacas.

Their small size allows them to access areas of the virus and human tissues that larger antibodies cannot.

Nanosota -EB1 andEB2 were especially effective, greatly improving survival rates in Ebola-infected mice.

VR Score

89

Informative language

94

Neutral language

78

Article tone

formal

Language

English

Language complexity

65

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links